These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 25538755

  • 21. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
    Liu B, Shen T.
    Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
    [Abstract] [Full Text] [Related]

  • 22. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
    Wu D, Jiang H, Gu Q, Zhang D, Li Z.
    Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
    [Abstract] [Full Text] [Related]

  • 23. Association between the XRCC1 Arg399Gln polymorphism and risk of cancer: evidence from 297 case-control studies.
    Yi L, Xiao-Feng H, Yun-Tao L, Hao L, Ye S, Song-Tao Q.
    PLoS One; 2013 Oct; 8(10):e78071. PubMed ID: 24205095
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis.
    Geng J, Zhang YW, Huang GC, Chen LB.
    World J Gastroenterol; 2008 Nov 21; 14(43):6733-7. PubMed ID: 19034980
    [Abstract] [Full Text] [Related]

  • 27. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
    Wang R, Hu X, Zhou Y, Feng Q, Su L, Long J, Wei B.
    Leuk Lymphoma; 2013 Jan 21; 54(1):153-9. PubMed ID: 22712837
    [Abstract] [Full Text] [Related]

  • 28. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
    Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, Jin K, Zhou D, Hu Q, Wang Q, Wang Z, Yan Z.
    Prostate Cancer Prostatic Dis; 2011 Sep 21; 14(3):225-31. PubMed ID: 21647176
    [Abstract] [Full Text] [Related]

  • 29. Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures.
    Saadat M, Ansari-Lari M.
    Breast Cancer Res Treat; 2009 May 21; 115(1):137-44. PubMed ID: 18481169
    [Abstract] [Full Text] [Related]

  • 30. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
    Zhang XL, Lu Y, Yang S, Peng QL, Wang J, Xie L, Deng Y, He Y, Li TJ, Qin X, Li S.
    Asian Pac J Cancer Prev; 2014 May 21; 15(7):3273-8. PubMed ID: 24815482
    [Abstract] [Full Text] [Related]

  • 31. The XRCC1 Arg399Gln genetic polymorphism contributes to hepatocellular carcinoma susceptibility: an updated meta-analysis.
    Pan Y, Zhao L, Chen XM, Gu Y, Shen JG, Liu LM.
    Asian Pac J Cancer Prev; 2013 May 21; 14(10):5761-7. PubMed ID: 24289575
    [Abstract] [Full Text] [Related]

  • 32. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
    Sun JY, Zhang CY, Zhang ZJ, Dong YF, Zhang AL, Wang ZW, Mei XL.
    Asian Pac J Cancer Prev; 2012 May 21; 13(9):4783-8. PubMed ID: 23167420
    [Abstract] [Full Text] [Related]

  • 33. XRCC1 gene polymorphisms and the risk of differentiated thyroid carcinoma (DTC): a meta-analysis of case-control studies.
    Bao Y, Jiang L, Zhou JY, Zou JJ, Zheng JY, Chen XF, Liu ZM, Shi YQ.
    PLoS One; 2013 May 21; 8(5):e64851. PubMed ID: 23717668
    [Abstract] [Full Text] [Related]

  • 34. The Arg399Gln polymorphism in the XRCC1 gene is associated with increased risk of hematological malignancies.
    Du L, Liu Y, Xue P, Song C, Shen J, He Q, Peng Y, Tong X, Tang L, Zhang Y.
    Tumour Biol; 2015 Jun 21; 36(6):4545-54. PubMed ID: 25619474
    [Abstract] [Full Text] [Related]

  • 35. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
    Warchoł T, Mostowska A, Lianeri M, Lącki JK, Jagodziński PP.
    DNA Cell Biol; 2012 Jan 21; 31(1):50-6. PubMed ID: 21682595
    [Abstract] [Full Text] [Related]

  • 36. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Wang L, Yin F, Xu X, Hu X, Zhao D.
    PLoS One; 2012 Jan 21; 7(4):e34897. PubMed ID: 22529951
    [Abstract] [Full Text] [Related]

  • 37. A population-based study of the Arg399Gln polymorphism in X-ray repair cross- complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma.
    Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT.
    Cancer Res; 2002 Aug 15; 62(16):4630-6. PubMed ID: 12183419
    [Abstract] [Full Text] [Related]

  • 38. XRCC1 and XPD genetic polymorphisms and susceptibility to age-related cataract: a meta-analysis.
    Chi XX, Liu YY, Shi SN, Cong Z, Liang YQ, Zhang HJ.
    Mol Vis; 2015 Aug 15; 21():335-46. PubMed ID: 25873778
    [Abstract] [Full Text] [Related]

  • 39. XRCC1 Arg280His polymorphism and glioma risk: A meta-analysis involving 1439 cases and 2564 controls.
    Zhang L, Wang Y, Qiu Z, Luo J, Zhou Z, Shu W.
    Pak J Med Sci; 2013 Jan 15; 29(1):37-42. PubMed ID: 24353504
    [Abstract] [Full Text] [Related]

  • 40. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
    Qian K, Liu KJ, Xu F, Chen XY, Chen GN, Yi WJ, Zhou EX, Tang ZH.
    Asian Pac J Cancer Prev; 2012 Jan 15; 13(12):6385-90. PubMed ID: 23464463
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.